SAN ANTONIO--(BUSINESS WIRE)--#BIAF--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW) (“bioAffinity” or the “Company”), a biotechnology ...
News
- bioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development
- AstraZeneca sees progress in obesity drug trials, highlights new oral option
Biotechnology · Transgene and ProBioGen join forces on cancer vaccines. 5 November 2024. Biotechnology · Nxera Pharma and Antiverse partner on GPCRs.
- Tampa biotech company NeuroEM aims to bring Alzheimer's treatment to market
San Antonio Inno · Seattle Inno · St. Louis Inno · Tampa Bay Inno · Triad Inno · Triangle Inno · Wichita Inno · Wisconsin Inno. Sign In. Sign In
- Viking Therapeutics' weight-loss pill shows 'great outcome' in trial - MSN
The data were released at Obesity Week, an event organized by the Obesity Society, taking place in San Antonio, Texas. Viking also presented data ...
- BioAge Labs to Present Preclinical Data for APJ Agonist Azelaprag at ObesityWeek 2024
The data will be presented at ObesityWeek 2024, held in San Antonio from November 2–6, 2024. "Our preclinical data highlight the potential of ...